- Home
- PECO vs APGE Comparison
PECO vs APGE Comparison
Compare PECO & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PECO | APGE |
|---|---|---|
| Founded | 1991 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PECO | APGE |
|---|---|---|
| Price | $36.22 | $75.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $38.33 | ★ $100.00 |
| AVG Volume (30 Days) | 760.9K | ★ 819.3K |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | ★ 37.32 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $711,781,000.00 | N/A |
| Revenue This Year | $10.41 | N/A |
| Revenue Next Year | $5.12 | N/A |
| P/E Ratio | $54.07 | ★ N/A |
| Revenue Growth | ★ 10.73 | N/A |
| 52 Week Low | $32.40 | $26.20 |
| 52 Week High | $39.70 | $78.15 |
Technical Indicators
Market Signals| Indicator | PECO | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 67.97 | 65.96 |
| Support Level | $34.49 | $74.48 |
| Resistance Level | $35.07 | $78.15 |
| Average True Range (ATR) | 0.50 | 3.22 |
| MACD | 0.07 | -0.47 |
| Stochastic Oscillator | 91.29 | 72.16 |
Price Performance
Historical ComparisonAbout PECO Phillips Edison & Company Inc.
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.